 Dyadic International Inc NASDAQ: DYAI stock is trading higher during the morning session on high volume after signing a COVID-19 vaccine technology transfer and licensing agreement with the Rubic Consortium. The South African-based company is focused on discovering, developing, evaluating, and manufacturing high-quality, cost-effective vaccines for distribution primarily to African markets. 